Carter Erin Catherine has filed 14 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 32 shares of Glucotrack, Inc. ($GCTK) on March 25, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2025 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 32 | $0.00 | 762.0000 | 0 | 4.38% | 0.00% |
| July 11, 2025 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 1000 | $0.00 | 1,762.0000 | 25,585,853 | 131.23% | 0.00% |
| Oct. 3, 2025 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 386 | $0.00 | 2,148.0000 | 25,585,853 | 21.91% | 0.00% |
| Oct. 3, 2025 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Stock option (right to buy) | 4055 | $0.00 | 4,055.0000 | 25,585,853 | 9999.99% | 0.02% |
| March 26, 2025 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 1896 | $0.00 | 45,632.0000 | 0 | 4.34% | 0.00% |
| July 18, 2024 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | P | Convertible Promissory Note | 50000 | $50000.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | C | Convertible Promissory Note | 64831 | $64831.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Dec. 31, 2023 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 903 | $0.00 | 903.0000 | 0 | 9999.99% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Series B Common Warrant | 2078 | $0.00 | 2,078.0000 | 0 | 9999.99% | 0.00% |
| March 12, 2025 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | X | Series B Common Warrant | 2078 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Series A Common Warrant | 2078 | $0.00 | 2,078.0000 | 0 | 9999.99% | 0.00% |
| April 8, 2024 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | A | Common Stock, par value $0.001 per share | 458 | $0.00 | 1,361.0000 | 0 | 50.72% | 0.00% |
| Nov. 14, 2024 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | C | Common Stock, par value $0.001 per share | 2078 | $31.20 | 3,439.0000 | 0 | 152.68% | 0.00% |
| March 12, 2025 | Glucotrack, Inc. | $GCTK | Carter Erin Catherine | Director | X | Common Stock, par value $0.001 per share | 40297 | $0.00 | 43,736.0000 | 0 | 1171.77% | 0.00% |